Adverse reaction of specific acute kidney injury caused by atorvastatin: an actual study based on the database of the US FDA adverse event reporting system
In the general population, evidence for a positive AKI signal was insufficient. However, subgroup analysis showed risk in males and older individuals in AMI and IS populations, while younger age groups in T2DM showed positive signals. In the HLD population, evidence was insufficient across genders and ages. Atorvastatin is generally safe, but clinical vigilance for AKI is needed in T2DM, AMI, and IS populations, especially in those 65 and older.
Authors
- Manting Liu (ORCID: https://orcid.org/0009-0004-7163-186X)
- Jiyuan Zheng (ORCID: https://orcid.org/0000-0003-3735-1309)
- Caishan Fang (ORCID: https://orcid.org/0000-0002-0543-994X)
- Jiazhen Jiang
- Hanlin Dong (ORCID: https://orcid.org/0009-0008-7871-0789)
- Dongqiang Luo
- Zhenye Chen
Institutions
- Guangzhou University of Chinese Medicine (CN)
- General Hospital of Guangzhou Military Command (CN)
- Chengdu University of Traditional Chinese Medicine (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-10-16
- DOI
- https://doi.org/10.1080/14740338.2024.2416919
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00